Terumo Corp Unsponsored ADR (TRUMY)
Terumo Corp ADR (TRUMY) is demonstrating improving relative strength within the Favored Green Zone in the SIA International ADR Report, ranking 60th out of 255 securities. Terumo has advanced 84 positions over the past month and 42 positions over the past quarter. The shares currently hold an SIA SMAX score of 10 out of 10.
The Health Services sector is positioned in the Neutral Yellow Zone of the SIA Sector Report, ranking 12th out of 31 sectors.
Terumo’s most recent Point and Figure signal is a Spread Double Top. Initial resistance is located at $17.46, followed by resistance at the 2025 high of $20.86. On a pullback, near-term support is located at the 3-box reversal level of $15.20, with additional support at the positive trend line near $12.97.
The shares have gained 15.02% over the past month and 8.43% over the past quarter, compared with gains of 4.83% and 4.46%, respectively, for the iShares MSCI ACWI ex US Index ETF. Over the past year, Terumo has declined 14.09%, while the benchmark has gained 26.24%.
Terumo manufactures and sells medical products and equipment in Japan and international markets. Its operations span cardiac and vascular products, medical care solutions, and blood and cell technologies.
The combination of a 10 out of 10 SIA SMAX score, a Favored Green Zone position, and the recent improvement in report ranking provides a technical framework through which investment professionals can assess the shares alongside their own investment objectives, risk parameters, and portfolio-management processes.
Disclaimer: SIACharts Inc. specifically represents that it does not give investment advice or advocate the purchase or sale of any security or investment whatsoever. This information has been prepared without regard to any particular investors investment objectives, financial situation, and needs. None of the information contained in this document constitutes an offer to sell or the solicitation of an offer to buy any security or other investment or an offer to provide investment services of any kind. As such, advisors and their clients should not act on any recommendation (express or implied) or information in this report without obtaining specific advice in relation to their accounts and should not rely on information herein as the primary basis for their investment decisions. Information contained herein is based on data obtained from recognized statistical services, issuer reports or communications, or other sources, believed to be reliable. SIACharts Inc. nor its third party content providers make any representations or warranties or take any responsibility as to the accuracy or completeness of any recommendation or information contained herein and shall not be liable for any errors, inaccuracies or delays in content, or for any actions taken in reliance thereon. Any statements nonfactual in nature constitute only current opinions, which are subject to change without notice.